NCT04709718

Brief Summary

Hepatic hemangiomas are the commonest benign mesenchymal lesions of the liver. Most of these lesions are asymptomatic. Giant hepatic hemangiomas (GHH) (\> 10 cm) are often symptomatic and require surgical intervention. This study aimed to describe the clinical findings, risk factors, diagnostic approach and management of GHH.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2008

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
11.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 29, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2020

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 1, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 14, 2021

Completed
Last Updated

January 14, 2021

Status Verified

January 1, 2021

Enrollment Period

11.5 years

First QC Date

January 1, 2021

Last Update Submit

January 13, 2021

Conditions

Liver Angioma

Outcome Measures

Primary Outcomes (1)

  • number of patient getting good result after surgery

    patient asymptomatic after surgery or not

    1 year

Study Arms (1)

churgery of geant liver hemangioma

Procedure: hepatectomy

Interventions

hepatectomyPROCEDURE

liver resection taking over the liver hemangioma

churgery of geant liver hemangioma

Eligibility Criteria

Age15 Years - 90 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patient with symptomatic geant liver hemangioma

You may qualify if:

  • Radiological diagnosis of geant liver hamangioma.

You may not qualify if:

  • Radiological diagnosis of liver hemangioma less than 10cm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Hepatectomy

Intervention Hierarchy (Ancestors)

Digestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • waad farhat, doctor

    university of sousse

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical professor

Study Record Dates

First Submitted

January 1, 2021

First Posted

January 14, 2021

Study Start

January 1, 2008

Primary Completion

June 29, 2019

Study Completion

January 2, 2020

Last Updated

January 14, 2021

Record last verified: 2021-01